WO2008087704A1 - 脳機能改善用組成物 - Google Patents

脳機能改善用組成物 Download PDF

Info

Publication number
WO2008087704A1
WO2008087704A1 PCT/JP2007/050477 JP2007050477W WO2008087704A1 WO 2008087704 A1 WO2008087704 A1 WO 2008087704A1 JP 2007050477 W JP2007050477 W JP 2007050477W WO 2008087704 A1 WO2008087704 A1 WO 2008087704A1
Authority
WO
WIPO (PCT)
Prior art keywords
improving
brain function
composition
brain
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/050477
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Fukami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mizkan Group Corp
Original Assignee
Mizkan Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mizkan Group Corp filed Critical Mizkan Group Corp
Priority to US12/448,568 priority Critical patent/US20100028465A1/en
Priority to EP07706804A priority patent/EP2103304A4/en
Priority to CNA2007800500265A priority patent/CN101610762A/zh
Priority to PCT/JP2007/050477 priority patent/WO2008087704A1/ja
Publication of WO2008087704A1 publication Critical patent/WO2008087704A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
    • C12J1/00—Vinegar; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

　本発明は、食品成分や天然抽出物などのように安全な素材であって、かつ、より強い脳機能改善効果（脳内神経伝達物質であるモノアミンの代謝を改善し、かつアセチルコリン作動性神経の機能低下による記憶、学習能の低下を改善する効果）を有する物質を提供するものである。 　本発明は、酢酸菌由来のアルカリ安定脂質、Ｎ－アシルスフィンガニンまたはＮ－２’－ヒドロキシパルミトイル－スフィンガニンを有効成分として含有することを特徴とする脳機能改善用組成物を提供するものである。
PCT/JP2007/050477 2007-01-16 2007-01-16 脳機能改善用組成物 Ceased WO2008087704A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US12/448,568 US20100028465A1 (en) 2007-01-16 2007-01-16 Composition for ameliorating cerebral function
EP07706804A EP2103304A4 (en) 2007-01-16 2007-01-16 COMPOSITION FOR IMPROVING BRAIN FUNCTION
CNA2007800500265A CN101610762A (zh) 2007-01-16 2007-01-16 脑功能改善用组合物
PCT/JP2007/050477 WO2008087704A1 (ja) 2007-01-16 2007-01-16 脳機能改善用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/050477 WO2008087704A1 (ja) 2007-01-16 2007-01-16 脳機能改善用組成物

Publications (1)

Publication Number Publication Date
WO2008087704A1 true WO2008087704A1 (ja) 2008-07-24

Family

ID=39635713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/050477 Ceased WO2008087704A1 (ja) 2007-01-16 2007-01-16 脳機能改善用組成物

Country Status (4)

Country Link
US (1) US20100028465A1 (ja)
EP (1) EP2103304A4 (ja)
CN (1) CN101610762A (ja)
WO (1) WO2008087704A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019078005A1 (ja) * 2017-10-18 2019-04-25 株式会社ダイセル アルツハイマー病の予防又は改善剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3038711T3 (en) * 2017-05-30 2025-10-14 Morinaga Milk Industry Co Ltd Acetic acid and/or an acetic acid salt for use in the treatment of alzheimer-type dementia

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717855A (ja) 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
JPH08188532A (ja) * 1995-01-04 1996-07-23 Hisashi Ishihara 食酢による血栓、動脈硬化予防治療技法
JP2001097869A (ja) * 1999-09-28 2001-04-10 Fuso Pharmaceutical Industries Ltd 新規抗腫瘍剤
JP2004051608A (ja) * 2002-07-24 2004-02-19 Tamanoi Vineger Co Ltd 大腸潰瘍の改善予防剤
JP2006199624A (ja) * 2005-01-20 2006-08-03 Mitsukan Group Honsha:Kk 酢酸菌体を含有する生体内抗酸化性組成物
JP2006199626A (ja) * 2005-01-20 2006-08-03 Mitsukan Group Honsha:Kk 酢酸菌セラミドを含む肌機能改善用組成物
JP2006345796A (ja) * 2005-06-17 2006-12-28 Mitsukan Group Honsha:Kk セラミド高生産性酢酸菌

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747567B1 (fr) * 1996-04-22 1998-05-22 Oreal Utilisation de ceramide pour le traitement des ongles
KR100487112B1 (ko) * 2002-08-03 2005-05-03 대한민국(관리부서:농촌진흥청) 백강잠 101ａ로부터 분리, 정제한 뇌신경성장 촉진물질(4ｅ, 6ｅ, 2ｓ,3ｒ)-2-ｎ-아이코사노일-4,6-테트라데카스핀게닌

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717855A (ja) 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
JPH08188532A (ja) * 1995-01-04 1996-07-23 Hisashi Ishihara 食酢による血栓、動脈硬化予防治療技法
JP2001097869A (ja) * 1999-09-28 2001-04-10 Fuso Pharmaceutical Industries Ltd 新規抗腫瘍剤
JP2004051608A (ja) * 2002-07-24 2004-02-19 Tamanoi Vineger Co Ltd 大腸潰瘍の改善予防剤
JP2006199624A (ja) * 2005-01-20 2006-08-03 Mitsukan Group Honsha:Kk 酢酸菌体を含有する生体内抗酸化性組成物
JP2006199626A (ja) * 2005-01-20 2006-08-03 Mitsukan Group Honsha:Kk 酢酸菌セラミドを含む肌機能改善用組成物
JP2006345796A (ja) * 2005-06-17 2006-12-28 Mitsukan Group Honsha:Kk セラミド高生産性酢酸菌

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"CMC Publishing CO., LTD.", 1988, article "Senile dementia and therapeutic agent", pages: 37 - 44
ACTA PSYCHIATRICA SCANDINAVICA, vol. 81, 1990, pages 265 - 270
HIDETSUGU GOTOU, DOCTOR THESIS OF GRADUATE SCHOOL OF AGRICULTURAL SCIENCES, IWATE UNIVERSITY, 2001, pages 11 - 41
HIDETSUGU GOTOU, DOCTOR THESIS OF GRADUATESCHOOL OF AGRICULTURAL SCIENCES, 2001, pages 11 - 41
JAPANISCH-DEUTSCHE MEDIZINISCH BERICHE, vol. 33, 1988, pages 319 - 330
MEDICINA, vol. 20, 1983, pages 2132 - 2133
RESEARCH BULLETIN OF OBIHIRO UNIVERSITY, vol. 23, 1978, pages 917 - 925
See also references of EP2103304A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019078005A1 (ja) * 2017-10-18 2019-04-25 株式会社ダイセル アルツハイマー病の予防又は改善剤
JPWO2019078005A1 (ja) * 2017-10-18 2020-11-05 株式会社ダイセル アルツハイマー病の予防又は改善剤
US11998559B2 (en) 2017-10-18 2024-06-04 Daicel Corporation Agent for preventing or ameliorating alzheimer's disease

Also Published As

Publication number Publication date
EP2103304A1 (en) 2009-09-23
CN101610762A (zh) 2009-12-23
EP2103304A4 (en) 2011-04-27
US20100028465A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
WO2007084314A3 (en) MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
NZ598950A (en) Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
WO2010136900A3 (en) Methods of using krill oil to treat risk factors for metabolic disorders and obesity
IN2012DN03632A (ja)
WO2007144770A3 (en) Bacterium
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2010074588A3 (en) Pharmaceutical compounds
Tan et al. Antioxidant activity and optimization of extraction of polysaccharide from the roots of Dipsacus asperoides
WO2011055019A3 (en) Feed composition comprising a birch bark extract and the use of a birch bark extract
IN2015DN02751A (ja)
MX2010009883A (es) Acidos dicarboxilicos de cadena media, sus derivados y enfermedades metabolicas.
WO2009048249A3 (en) Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same
PH12015502263A1 (en) Composition for preventing or treating hangover
WO2018169282A3 (ko) Atpif1을 함유하는 당뇨 치료용 약학조성물
WO2019098553A3 (ko) 다당류 함량이 증진된 녹차 추출물을 유효성분으로 포함하는 조성물
EE201400038A (et) Hüpokolestereemilist ja antimikroobset agenti probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ja Clostridium difficile põhjustatava kõhulahtisuse ennetamisek
WO2011077163A3 (en) Use
WO2010108051A3 (en) Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof
WO2008099801A1 (ja) 乳酸菌生残性向上剤
MY161065A (en) Flavor improving materials
CN105494479A (zh) 一种空气清新剂
BRPI0416747A (pt) métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada
WO2011013999A3 (ko) 키토올리고당을 함유하는 피로회복용 조성물
WO2010041908A3 (ko) 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780050026.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07706804

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12448568

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2007706804

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP